My Eyes, My Light: Amar Chokh, Amar Alo
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This trial is studying people living in Char Fasson, Bangladesh, to see who might have undiagnosed eye problems. It's a local screening program to catch eye issues early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 35 years of age or older.
- You must live in the Char Fasson sub-district (Bhola District).
- You should not have a known eye disease diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a village-based approach to bring eye care closer to older community members. If you live in the right area and are willing to participate, it may help improve access to eye screening and services.
This study helps connect people in rural Assam who need eye surgery or hospital care. It helps make sure referrals are completed and that you get the surgery you need.
This study tests a program that combines diabetes care with eye exams for people in Bangladesh who were recently diagnosed with diabetes. The goal is to see if this approach helps you better manage your health and prevent vision problems.
This trial tests a new mobile screening method to help find eye diseases early so they can be treated sooner. It may be helpful for people who want a quick and easy eye check.
This study tests a new way to combine diabetes care with eye care for people with diabetes in Bangladesh. If you have diabetes and a diabetes-related eye condition, this might help improve your care.
This trial screens adults in Rawalpindi for eye problems and helps them get referred to a specialist hospital to prevent avoidable blindness. If you have an untreated eye issue, this program can connect you with the care you need.
Hear when a new Glaucoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.